Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAS-114 + S-1 in advanced NSCLC
NCT02855125Phase 2Completed
- Sponsor
- Taiho Oncology
- Start
- Aug 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of TAS-114 in non-small cell lung cancer (NSCLC), sponsored by Taiho Oncology. Started Aug 2016; status: completed.
02
Drugs
TAS-114
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02855125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02855125.